Veri Medtech (VRHI) Relaunches DosePop.com
Veri Medtech (VRHI) has announced the relaunch of its healthcare technology platform DosePop.com. According to CEO Sam Adetunji, the platform serves as a connector between patients and physicians, focusing on enabling individuals to manage various aspects of their health and well-being, ranging from weight loss to hair loss treatments.
Veri Medtech (VRHI) ha annunciato il rilancio della sua piattaforma tecnologica sanitaria DosePop.com. Secondo il CEO Sam Adetunji, la piattaforma funge da collegamento tra pazienti e medici, con l'obiettivo di permettere agli individui di gestire diversi aspetti della loro salute e benessere, che vanno dalla perdita di peso ai trattamenti per la caduta dei capelli.
Veri Medtech (VRHI) ha anunciado el relanzamiento de su plataforma tecnológica de salud DosePop.com. Según el CEO Sam Adetunji, la plataforma actúa como un nexo entre pacientes y médicos, enfocándose en permitir a las personas gestionar diversos aspectos de su salud y bienestar, desde la pérdida de peso hasta tratamientos para la caída del cabello.
Veri Medtech (VRHI)는 의료 기술 플랫폼 DosePop.com의 재출시를 발표했습니다. CEO Sam Adetunji에 따르면, 이 플랫폼은 환자와 의사를 연결하는 역할을 하며, 체중 감량부터 탈모 치료에 이르기까지 개인이 건강과 웰빙의 다양한 측면을 관리할 수 있도록 지원하는 데 중점을 두고 있습니다.
Veri Medtech (VRHI) a annoncé la relance de sa plateforme technologique de santé DosePop.com. Selon le PDG Sam Adetunji, cette plateforme sert de lien entre les patients et les médecins, en mettant l'accent sur la possibilité pour les individus de gérer divers aspects de leur santé et bien-être, allant de la perte de poids aux traitements contre la chute des cheveux.
Veri Medtech (VRHI) hat die Wiederaufnahme seiner Gesundheitstechnologie-Plattform DosePop.com angekündigt. Laut CEO Sam Adetunji dient die Plattform als Verbindung zwischen Patienten und Ärzten und konzentriert sich darauf, Menschen zu ermöglichen, verschiedene Aspekte ihrer Gesundheit und ihres Wohlbefindens zu verwalten, von Gewichtsverlust bis hin zu Behandlungen gegen Haarausfall.
- None.
- None.
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Veri Medtech (Stock Ticker Symbol: “VRHI”) announced today the relaunch of its DosePop.com healthcare technology platform. For more information, please visit: www.DosePop.com.
“Veri Medtech (VRHI) healthcare technology platform – DosePop.com serves as a powerful connector bringing patients and physicians together to enable and empower individuals to manage their well-being and quality of life from weight loss to hair loss and everything in between," said Sam Adetunji, CEO, Veri Medtech Holdings.
About DosePop: DosePop, a wholly-owned subsidiary of publicly-traded Veri Medtech (Stock Ticker Symbol: “VRHI”), provides a one-stop healthcare technology platform for mental and physical health, all designed to empower you to take charge of your well-being. From weight loss solutions to anti-aging, our treatments are backed by science and administered by licensed professionals. For more information, please visit: www.DosePop.com.
About Veri Medtech Holdings, Inc. (Stock Ticker Symbol: VRHI): Veri Medtech is a publicly-traded healthcare technology company that offers alternative medicine, personalized diagnostics, and wellness medication on demand. The company leverages telehealth infrastructure, diagnostic intelligence, and scalable digital systems to meet the growing demand for accessible, stigma-free healthcare. Strategically positioned for growth, Veri MedTech actively explores acquisitions that complement its core capabilities and enhance patient engagement across emerging sectors of alternative medicine, longevity, and wellness science. With a strong integration and operational efficiency track record, the company drives accelerated revenue through the continuous generation of high-value patient databases and recurring service models. With a commitment to innovation and patient-centric care, Veri MedTech continues to expand its services and reach, aiming to make personalized healthcare more accessible and effective for all. For more information, please visit: www.VeriMedTech.com.
About Veriheal: Veriheal, a wholly-owned subsidiary of publicly-traded Veri Medtech Holdings – (Stock Ticker Symbol: “VRHI”) is a healthcare technology company on a mission to help real people get real medicine. For more information, please visit: www.Veriheal.com.
Forward Looking Statements: Cautionary Note Regarding Forward-Looking Statements: This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Veri Medtech (OTC Markets: "VRHI") and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements.
PR Inquiries: pr@verimedtech.com
FAQ
What is DosePop.com by Veri Medtech (VRHI)?
When did Veri Medtech (VRHI) relaunch DosePop.com?
Who is the CEO of Veri Medtech (VRHI)?
What services does DosePop.com offer?
